We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.1B
AUM Growth
+$273M
Cap. Flow
-$650M
Cap. Flow %
-4.61%
Top 10 Hldgs %
32.88%
Holding
703
New
–
Increased
221
Reduced
319
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.6M
2
NVDA icon
NVIDIA
NVDA
+$36M
3
ISRG icon
Intuitive Surgical
ISRG
+$33.8M
4
AMAT icon
Applied Materials
AMAT
+$32.4M
5
XP icon
XP
XP
+$31M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$57.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$54.9M
3
DHR icon
Danaher
DHR
+$41.9M
4
MSFT icon
Microsoft
MSFT
+$40.7M
5
LRCX icon
Lam Research
LRCX
+$37.4M

Sector Composition

Rank Sector Weight
1 Healthcare 26.08%
2 Technology 25.64%
3 Financials 11.81%
4 Industrials 7.9%
5 Materials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOOP icon
476
Loop Industries
LOOP
$35.3M
$1.48M 0.01%
413,327
– –
IGMS
477
DELISTED
IGM Biosciences
IGMS
$1.46M 0.01%
175,008
– –
MKL icon
478
Markel Group
MKL
$23.3B
$1.44M 0.01%
981
-122
-11% -$179K
DG icon
479
Dollar General
DG
$28B
$1.44M 0.01%
13,591
-17,839
-57% -$2.66M
VMC icon
480
Vulcan Materials
VMC
$34.8B
$1.44M 0.01%
6,935
-1,202
-15% -$261K
BDTX icon
481
Black Diamond Therapeutics
BDTX
$96.8M
$1.44M 0.01%
500,009
– –
HWM icon
482
Howmet Aerospace
HWM
$113B
$1.43M 0.01%
30,918
– –
DOC icon
483
Healthpeak Properties
DOC
$15.1B
$1.43M 0.01%
77,636
+10,126
+15% +$208K
ARKK icon
484
ARK Innovation ETF
ARKK
$5.64B
$1.41M 0.01%
35,520
– –
FITB
485
Fifth Third Bancorp
FITB
$51.2B
$1.41M 0.01%
55,468
-69,486
-56% -$1.87M
OMC icon
486
Omnicom Group
OMC
$21.6B
$1.4M 0.01%
18,834
+960
+5% +$79.1K
MEDP icon
487
Medpace
MEDP
$16.1B
$1.39M 0.01%
5,750
-4,144
-42% -$1.06M
SJM icon
488
J.M. Smucker
SJM
$12.7B
$1.39M 0.01%
11,286
-711
-6% -$101K
IFF icon
489
International Flavors & Fragrances
IFF
$20.2B
$1.39M 0.01%
20,323
-15,483
-43% -$1.13M
BAH icon
490
Booz Allen Hamilton
BAH
$8.39B
$1.38M 0.01%
12,611
-3,182
-20% -$366K
EFX icon
491
Equifax
EFX
$20.3B
$1.37M 0.01%
7,464
-618
-8% -$126K
GEHC icon
492
GE HealthCare
GEHC
$30.7B
$1.36M 0.01%
20,015
-1,547
-7% -$113K
SHOP icon
493
Shopify
SHOP
$152B
$1.36M 0.01%
24,844
-101,337
-80% -$6.14M
MLM icon
494
Martin Marietta Materials
MLM
$31.5B
$1.34M 0.01%
3,269
– –
GLW icon
495
Corning
GLW
$119B
$1.32M 0.01%
43,356
+522
+1% +$17.1K
CNI icon
496
Canadian National Railway
CNI
$76.9B
$1.32M 0.01%
12,096
-5,362
-31% -$615K
IRM icon
497
Iron Mountain
IRM
$36.4B
$1.31M 0.01%
22,064
– –
HRL icon
498
Hormel Foods
HRL
$13.8B
$1.3M 0.01%
34,201
+3,241
+10% +$128K
RJF icon
499
Raymond James Financial
RJF
$33.8B
$1.28M 0.01%
12,710
– –
PLTR icon
500
Palantir
PLTR
$295B
$1.27M 0.01%
79,202
+749
+1% +$11.9K
18 19
20
21 22

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q3 2023 Portfolio in Review

As of Q3 2023, Candriam SCA held 703 positions worth $14.1B, up 2% from $13.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Candriam SCA withdrew a net $650M in Q3 2023, closing 43 positions and reducing 319 holdings. Its most notable exit was Chinook Therapeutics, Inc. Common Stock, an estimated $31.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA added an estimated $41.6M to Amgen.

  • Candriam SCA added most to Amgen in Q3 2023, an estimated $41.6M increase.
  • Candriam SCA's biggest Q3 2023 reduction was Visa, cutting an estimated $57.8M.
  • Candriam SCA fully exited Chinook Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $31.7M.
  • Candriam SCA's ten largest holdings make up 33% of its $14.1B portfolio in Q3 2023.
  • Candriam SCA opened 0 new positions and closed 43 in Q3 2023.
  • Candriam SCA's portfolio value rose 2% quarter-over-quarter to $14.1B.

Based on Candriam SCA's 13F filing for Q3 2023, filed 13 Nov 2023.